Abstract
New information on the etiology, prevention and management of lower respiratory infections has become available over the past three to four years. This editorial will try to put into perspective developments in the following four areas: 1) the increased resistance of pneumococci to penicillin; 2) results of recent pneumococcal vaccine studies; 3) TWAR strains ofChylamydia psittaci as causative agents in atypical pneumonia; and 4) respiratory infections, particularly tuberculosis, in patients with AIDS.
References
Austrian, R.: Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Annals of Internal Medicine 1964, 60: 759–776.
Jacobs, M.R., Koornhof, H. J., Robins-Browne, R. M., Stevenson, C. M., Vermaak, Z. A., Freiman, I., Miller, G. B., Witcomb, M. A., Isaacson, M., Ward, J. I., Austrian, R.: Emergence of multiply resistant pneumococci. New England Journal of Medicine 1978, 299: 735–740.
Ward, J.: Antibiotic-resistantStreptococcus pneumoniae: clinical and epidemiologic aspects. Reviews of Infectious Diseases 1981, 3: 254–266.
Jacobs, M. R., Mithal, Y., Robins-Browne, R. M., Gaspar, M. N., Koornhof, H. J.: Antimicrobial susceptibility testing of pneumococci: determination of Kirby Bauer breakpoints for penicillin G, erythromycin, clindamycin, tetracycline, chloramphenicol and rifampin. Antimicrobial Agents and Chemotherapy, 1979, 16: 190–197.
Jackson, M. A., Shelton, S., Nelson, J. D., McCracken, G. H.: Relatively penicillin-resistant pneumococcal infections in pediatric patients. Pediatric Infectious Disease 1984, 3: 129–132.
McCracken, G. H., Sakata, Y.: Antimicrobial therapy of experimental meningitis caused byStreptococcus pneumoniae strains with different susceptibilities to penicillin. Antimicrobial Agents and Chemotherapy 1985, 27: 141–145.
Radetsky, M. S., Istre, G. R., Johansen, T. L., Parmalee, S. W., Lauer, B. A., Wiesenthal, A. M., Glode, M. P.: Multiply resistant pneumococcus causing meningitis: its epidemiology within a day-care center. Lancet 1981, ii: 771–773.
Linares, J., Perez, J. L., Garau, J., Murgui, L., Martin, R.: Comparative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin and fourteen beta-lactam antibiotics. Journal of Antimicrobial Therapy 1984, 13: 353–359.
Pallares, R., Gudiol, F., Linares, J., Ariza, J., Rufi, G., Murgui, L., Dorca, J., Viladrich, P. F.: Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. New England Journal of Medicine 1987, 317: 18–22.
Immunization Practices Advisory Committee: Update: pneumococcal polysaccharide vaccine usage — United States. Morbidity and Mortality Weekly Report 1984, 33: 273–281.
Austrian, R., Douglas, R. M., Schiffman, G.: Prevention of pneumococcal pneumonia by vaccination. Transactions of the Association of American Physicians 1976, 89: 184–194.
Kaufman, P.: Pneumonia in old age: active immunization against pneumonia with pneumococcus polysaccharide; results of a six year study. Archives of Internal Medicine 1947, 79: 518–531.
Broome, C. V.: Efficacy of pneumococcal vaccines. Reviews of Infectious Diseases 1981, 3, Supplement: 82–88.
Simberkoff, M. S., Cross, A. P., Al-Ibrahim, M., Baltch, A. L., Geiseler, P. J., Nadler, J., Richmond, A. S., Smith, R. P., Schiffman, G., Shepard, D. S., Van Eekhout, J. P.: Efficacy of pneumococcal vaccine in high-risk patients. New England Journal of Medicine 1986, 315: 1318–1327.
Austrian, R.: A reassessment of pneumococcal vaccine. New England Journal of Medicine 1984, 310: 651–653.
Bolan, G., Broome, C. V., Facklam, R. R., Plikaytis, B. D., Fraser, D. W., Schlech, W. F.: Pneumococcal vaccine efficacy in selected populations in the United States. Annals of Internal Medicine 1986, 104: 1–6.
Schachter, J.:Chlamydia psittaci — “Reemergence” of a forgotten pathogen. New England Journal of Medicine 1986, 315: 189–191.
Tack, K. J., Peterson, P. K., Rasp, F. L., O'Leary, M., Hanto, D., Simmons, R. L., Sabath, L. D.: Isolation ofChlamydia trachomatis from the lower respiratory tract of adults. Lancet 1980, i: 116–120.
Komaroff, A. L., Aronson, M. D., Schachter, J.:Chlamydia trachomatis infection in adults with community acquired pneumonia. Journal of the American Medical Association 1981, 245: 1319–1322.
Saikku, P., Wang, S. P., Kleemola, M., Brander, E., Rusanen, E., Grayston, J. T.: An epidemic of mild pneumonia due to an unusual strain ofChlamydia psittaci. Journal of Infectious Diseases 1985, 151: 832–839.
Grayston, J. T., Kuo, C. C., Wang, S. P., Altman, J.: A newChlamydia psittaci strain TWAR isolated from acute respiratory tract infections. New England Journal of Medicine 1986, 315: 161–168.
Marrie, T.J., Grayston, T. J., Wang, S., Kuo, C.: Pneumonia associated with the TWAR strain of chlamydia. Annals of Internal Medicine 1987, 106: 507–511.
Pitchenik, A. E., Ganjei, P., Torres, A., Evans, D. A., Rubin, E., Baier, H.: Sputum examination for the diagnosis ofPneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. American Review of Respiratory Diseases 1986, 133: 226–229.
Murray, J. F., Felton, C. P., Garay, S. M., Gottlieb, M. S., Hopewell, P. C., Stover, D. E., Teirstein, A. S.: Pulmonary complications of the acquired immunodeficiency syndrome. New England Journal of Medicine 1984, 310: 1682–1688.
Murray, J. F., Garay, S. M., Hopewell, P. C., Mills, J., Snider, G. L., Stover, D. E.: Pulmonary complications of the acquired immunodeficiency syndrome: an update. American Review of Respiratory Diseases 1987, 135: 504–509.
Centers for Disease Control: Tuberculosis — United States, 1985 — and the possible impact of human Tlymphotropic virus type III/lymphadenopathy-associated virus infection. Morbidity and Mortality Weekly Report 1986, 35: 74–76.
Sunderam, G., McDonald, R. J., Maniatis, T.: Tuberculosis as a manifestation of the acquired immunodeficiency syndrome. Journal of the American Medical Association 1986, 256: 362–366.
Chaisson, R. E., Schecter, G. F., Theuer, C. P., Rutherford, G. W., Echenberg, D. F., Hopewell, P. C.: Tuberculosis in patients with the acquired immunodeficiency syndrome. American Review of Respiratory Diseases 1987, 136: 570–574.
Pitchenik, A. E., Cole, C., Russell, B. W., Fischl, M. A., Spira, T. J., Snider, D. E.: Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in South Florida. Annals of Internal Medicine 1984, 101: 641–645.
Polsky, B., Gold, J. W. M., Whimbey, E., Dryjanski, J., Brown, A. E., Schiffman, G., Armstrong, D.: Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Annals of Internal Medicine 1986, 104: 38–41.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
LaForce, F.M. Pneumonia — 1987: New developments. Eur. J, Clin. Microbiol. 6, 613–617 (1987). https://doi.org/10.1007/BF02013054
Issue Date:
DOI: https://doi.org/10.1007/BF02013054